These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23296464)

  • 21. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
    Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
    J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
    Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer screening in Teresina, Piauí, Brazil: evaluation study using data of the Cervical Cancer Information System, 2006-2013.
    Damacena AM; Luz LL; Mattos IE
    Epidemiol Serv Saude; 2017; 26(1):71-80. PubMed ID: 28226009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An optoelectronic cervical cancer screening system for screening cervical cancer: comparison with cervical cytology].
    He XK; Luo XP; Mao LZ; Chen GY; Li Y; Zhang JY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2304-6. PubMed ID: 20965832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical Cancer Detection between Conventional and Liquid Based Cervical Cytology: a 6-Year Experience in Northern Bangkok Thailand.
    Phaliwong P; Pariyawateekul P; Khuakoonratt N; Sirichai W; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2018 May; 19(5):1331-1336. PubMed ID: 29802695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
    Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
    Gyllensten U; Sanner K; Gustavsson I; Lindell M; Wikström I; Wilander E
    Br J Cancer; 2011 Aug; 105(5):694-7. PubMed ID: 21811250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pap smear accuracy for the diagnosis of cervical precancerous lesions.
    Nkwabong E; Laure Bessi Badjan I; Sando Z
    Trop Doct; 2019 Jan; 49(1):34-39. PubMed ID: 30222058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
    Bao H; Bi H; Zhang X; Zhao Y; Dong Y; Luo X; Zhou D; You Z; Wu Y; Liu Z; Zhang Y; Liu J; Fang L; Wang L
    Gynecol Oncol; 2020 Oct; 159(1):171-178. PubMed ID: 32814641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The diagnostic value of cytology and colposcopy in women with cervical intraepithelial neoplasia].
    Wojciech R
    Ginekol Pol; 2011 Aug; 82(8):607-11. PubMed ID: 21957606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
    Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
    Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device.
    Stenvall H; Wikström I; Backlund I; Wilander E
    Acta Obstet Gynecol Scand; 2007; 86(1):16-21. PubMed ID: 17230283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 37. Histopathological correlation of squamous cell abnormalities detected on cervical cytology.
    Abali R; Bacanakgıl BH; Celık S; Aras O; Koca P; Boran B; Dursun N
    Turk Patoloji Derg; 2011 May; 27(2):144-8. PubMed ID: 21630201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer.
    Upendram P; Sahni S; Mohiuddin K; Poornima S; Gourishankar B; Kumar Vattam K; Boddala P; Jayashankar E; Mohiuddin S; Kamineni V; Mohan V; Houldsworth J; Hasan Q
    Tumour Biol; 2017 Oct; 39(10):1010428317698363. PubMed ID: 28990460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
    Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.